Oligodendrocytes are specialised glial cells that myelinate CNS axons. Myelinated axons are bundled together into white matter tracts that interconnect grey matter areas of the brain and are essential for rapid, integrated neuronal communication and cognitive function. Lifelong generation of oligodendrocytes is required for myelination of new neuronal connections and repair of myelin lost through natural 'wear and tear'. This is the function of a substantial population of adult oligodendrocyte progenitors (OPs). Notably, there is white matter shrinkage and decreased myelination in the ageing brain, which is accelerated in dementia. The underlying causes of myelin loss in dementia are unresolved, but it implies a decline in the regenerative capacity of OPs. A feature of OPs is that they form neuron-glial synapses and respond to glutamate released by neurons via a range of glutamate receptors.
INTRODUCTION
The massive computing power of the human brain depends on bundles of myelinated axons that form the white matter which interconnects widely dispersed neuronal networks in the grey matter areas of the brain. Myelin is produced by specialised cells called oligodendrocytes that insulate nerve cell axons or fibres to form the white matter and is essential for cognitive functions [1] . Notably, myelin is generated throughout life by oligodendrocyte progenitors (OPs), but declines in humans after 50 years of age. White matter loss is among the earliest brain changes in Alzheimer's disease (AD), preceding the tangles and plaques that characterize neuronal deficits [2] . This has led to the hypothesis that myelin loss may be related to a failure in recruiting OPs in the ageing brain, which is accelerated in AD. Furthermore, synaptic activity is believed to be important in regulating both the expansion of OPs and their differentiation into oligodendrocytes. Here, we propose that disruption of synaptic signalling in AD may be important in the decreased capacity for OP regeneration.
Oligodendrocytes and myelin are generated throughout adult life
In humans, white matter volume steadily increases until the age of 50, but declines thereafter [3] . Studies in primates and rodents provide evidence that the generation of new oligodendrocytes in the adult is essential for continued growth and replacement of myelin loss through natural 'wear and tear' [4, 5] . Learning in adult humans and rodents results in structural changes in white matter and formation of new neuronal connections that depend on oligodendrocytes for myelination [6, 7] . Fate-map studies in mice demonstrate that new oligodendrocytes are generated from a pool of adult OPs [5, 8, 9] . Adult OPs are primarily identified by their expression of NG2 and PDGFR and represent the largest proliferative cell population in the adult brain [10] . Like stem cells, OPs divide asymmetrically to form 'sister OPs', one for self-renewal of the OP population and the other differentiates into an oligodendrocyte. In this way, adult OPs generate new oligodendrocytes at a slow rate throughout life and this is increased following CNS injury or demyelination, where proliferation of OPs is vital for regenerating oligodendrocytes and myelin [5, [11] [12] [13] [14] [15] .
However, OP's capacity for self-renewal decreases with age [5, 16, 17] . This is concomitant with white matter shrinkage and an accumulation of white matter lesions in the ageing brain [18] , which appears to be due to a combination of myelin loss and a decline in remyelination [19] . This has led to the hypothesis that decreased recruitment of OPs is central to the failure of myelination in the ageing brain [20] [21] [22] . Moreover, a failure of oligodendrocyte regeneration from OPs is a major feature of multiple sclerosis (MS), amyotrophic lateral sclerosis sclerosis (ALS), and stroke, emphasizing the criticality of regenerative processes in maintenance and functioning of the nervous system [20, 23, 24] .
Oligodendrocyte and myelin pathology are major factors in AD
The loss of myelin with age is central to cognitive decline in dementia [3] . MRI studies indicate that myelin loss contributes to the cognitive deficits observed in dementia through disruption of rapid transmission and the loss of synchronization of higher cognitive functions [25] . Ultrastructural analysis of the normal ageing brain has confirmed a 20% decrease in the number of myelinated nerve fibres of cerebral white matter fibre tracts associated with frontal lobe areas critical in cognitive processing [26] . Post-mortem studies have identified myelin loss from frontal and temporal lobes as a key feature of vascular dementia, dementia with Lewy bodies and AD [27] . Furthermore, myelin disruption has been demonstrated as an early feature of animal models of AD, correlating with the earliest appearance of Aβ accumulation in the 3×Tg-AD mouse model [28] . There is clear evidence of Aβ toxicity in oligodendrocytes [29, 30] , and myelin disruption is correlated with increased levels of Aβ in human AD [31] . The close correlation between myelination defects and learning/memory deficits implicate loss of oligodendrocytes early in disease-related cognitive decline.
Synaptic control of myelination
There is evidence that OPs receive instructive signals from axons for myelination in an activity dependent manner via glutamate signalling [32, 33] . A key feature of OPs is that they form synapses with neurons and respond to glutamate released by neurons at grey matter synapses and along white matter axons [34] [35] [36] [37] [38] [39] . OPs have prominent expression of both AMPA-and NMDA-type glutamate receptors, with evidence that activation of AMPA receptors regulates OP proliferation and migration [2, 6] , and NMDA receptors mediate activity-dependent myelination [7, 32] . Axons have mechanisms for vesicular release of glutamate during action potential propagation [37, 38, 40] and glutamate signalling provides a mechanism of adaptive myelination of electrically active axons [7, 32] . Blockade of axonal electrical activity slows down OP proliferation and myelination, whereas stimulation increases OP proliferation and myelination [41] [42] [43] . In addition, AMPA and NMDA receptors are expressed by mature oligodendrocytes and myelin, which has led to the hypothesis that communication between axons and myelin represents a new type of 'axon-myelin synapse'
[44]. After demyelination, neuron-OP synapses are formed during spontaneous remyelination, suggesting that synaptic glutamate signalling is important in the early stages of remyelination [45] . Thus, myelination/remyelination is dependent on axonal electrical activity and glutamatergic signalling even in adulthood.
Neurotransmission is altered in ageing white matter
Many studies have demonstrated that in AD synaptic activity is impaired in grey matter, e.g. in the 3xTg-AD mouse [46] . However, white matter has been largely overlooked in this context. We have used a whole genomic approach to examine neurotransmission in the ageing mouse optic nerve, one of the most commonly studied white matter preparations, which we and others have shown has prominent glutamate-mediated signalling [47] .
Microarray analysis highlights the prominent expression of transcripts for vesicular release machinery in CNS white matter, with significant changes in the SNAP-SNARE complex, from SNAP23/Synaptobrevin2/Synaptotagmin4/syntaxin6,7 in the mature adult nerve to SNAP25/Cellubrevin/Synaptotagmin4/syntaxin12 in the 18-month ageing optic nerve ( Figure   1 ). Differential regulation of synaptic proteins in the frontal and temporal cortex is a feature of the ageing brain and AD [48] . Our analysis of the optic nerve indicates similar important age-related changes in synaptic signaling in CNS white matter, which may play a role in white matter loss in AD. Moreover, altered synaptic signaling is implicated in other neuropathologies in which OP regeneration is compromised, including MS, ALS, and stroke, further emphasizing how critical these mechanisms for the maintenance of CNS function [20, 23, 24, 47] . Microarray analysis of transcripts for the different glial cell types indicates a clear reduction of oligodendrocyte/myelin genes with age ( Figure 2A) . Notably, there was a marked decrease in the OP marker Pdgfra in the aging nerve, as well striking decreases in transcription factors that regulate OP differentiation -Nkx2.2, Sox10 and Olig2 (Figure 2A ) -which are essential for initiating oligodendrocyte differentiation [49] . The microarray analysis also indicated increased glutamatergic and GABAergic signaling in the ageing optic nerve, whereas purinergic and adenosine signaling were proportionally decreased ( Figure   2C ). Purine receptors mediate both oligodendrocyte protection and destruction, and dysregulation of purine signaling may be important in white matter shrinkage in the ageing brain [50] . GABA signalling was highest in the ageing nerve and inhibits OP proliferation [51] , and increased glutamatergic signaling is consistent with oligodendrocyte pathology [23, 47] . Closer examination of glutamate receptors identified marked changes in vesicular glutamate transporters and NMDA receptors in the ageing optic nerve, with an 80-fold increase in the vesicular glutamate transporter VGLUT1 and a 25-fold increase in GluN2B and GluN2C ( Figure 2C ). OPs express GluN1, GluN2B and GluN2D, whereas oligodendrocyte NMDA receptors are likely to be formed from two GluN1, one GluN2 and one GluN3 subunit, which reduces their Mg 2+ block and makes them active at resting membrane potential [52] [53] [54] . In addition, OPs express AMPA receptors that have significant Ca Figure 3D ). This is consistent with changes in NG2 cells in human AD [57] and demonstrate disruption of OPs is an early feature of the disease and precedes overt myelin loss and synaptic dysfunction.
Summary and Conclusions
Studies by ourselves and others have demonstrated that neurotransmitter signalling is a prominent feature of white matter. [58] , and a study in the 3xTg-AD mouse brain has described that increased synaptic spontaneous vesicular glutamate release is an early feature of the disease [59] . These studies paint a picture in AD of a vicious cycle of disruption of synaptic glutamate signalling and impaired OP regenerative potential, coupled with loss of oligodendrocytes and myelin, resulting in further impairment of synaptic signaling and OP recruitment. In this respect, NMDA receptors are central to both neuronal and oligodendrocyte/myelin pathology. Memantine blocks excessive NMDA receptor activation and is an effective treatment for both mild and moderate-to-severe AD [60] . The increase in NMDA receptors indicated in our analysis of ageing white mater suggests that oligodendroglial NMDA receptors may be a target of memantine in AD, rescuing white matter and breaking the cycle of synaptic disruption and oligodendrocyte/myelin loss. , and fold-changes in the levels og transcripts associated with glutamate signaling(C). There was marked increase in vesicular glutamate transporter VGLUT1 and NMDA-receptor subunits GluN2A and GluN2B, in addition to a 3-fold decrease in the glial glutamate uptake transporter GLAST1. These changes in multiple aspects of glutamate signaling correlate with dysregulation of genes involved in OP differentiation and myelination in ageing white matter. In addition, an increase in glutamate release and decrease in glutamate uptake, coupled with and increase in oligodendroglial NMDA receptors, would have potential pathological consequences for oligodendrocytes/myelin, resulting in white matter shrinkage and cognitive decline. Hence, blocking excessive activation of oligodendroglial NMDA receptors with memantine, which is an effective treatment for AD, would potentially rescue white matter loss in AD and slow down cognitive decline. Glutamate released vesicularly by axons acts on AMPA-and NMDAtype receptors on OPs and oligodendrocytes to regulate myelination and mediate myelin pathology in CNS white matter. 
